Mangoceuticals, Inc.
MGRX
$2.49
-$0.08-3.11%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 58.70K | 73.90K | 490.20K | 15.30K | 739.00K |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | 13.20K | 14.00K | 14.50K | 18.50K |
Prepaid Expenses | -- | -- | -- | 60.10K | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 16.90K | 16.90K | 13.30K | -- | 77.90K |
Total Current Assets | 75.60K | 104.10K | 517.60K | 89.80K | 835.40K |
|
|||||
Total Current Assets | 75.60K | 104.10K | 517.60K | 89.80K | 835.40K |
Net Property, Plant & Equipment | 182.10K | 197.80K | 213.10K | 194.70K | 215.40K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 15.23M | 14.61M | 14.61M | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -119.80K | -119.80K | -102.90K | 16.90K | -- |
Total Assets | 15.37M | 14.79M | 15.24M | 301.40K | 1.05M |
|
|||||
Total Accounts Payable | 837.50K | 754.00K | 718.70K | 1.05M | 140.80K |
Total Accrued Expenses | -- | 5.60K | 4.70K | 8.20K | 6.60K |
Short-term Debt | 150.00K | 187.50K | 187.50K | 87.50K | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 65.00K | 69.30K | 67.40K | 65.60K | 63.70K |
Total Finance Division Other Current Liabilities | 373.00K | 375.00K | 400.00K | -- | -- |
Total Other Current Liabilities | 373.00K | 375.00K | 400.00K | -- | -- |
Total Current Liabilities | 1.43M | 1.39M | 1.38M | 1.21M | 211.10K |
|
|||||
Total Current Liabilities | 1.43M | 1.39M | 1.38M | 1.21M | 211.10K |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 150.00K | 187.50K | 187.50K | 87.50K | -- |
Capital Leases | -- | 12.20K | 30.10K | 47.70K | 65.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 1.43M | 1.40M | 1.41M | 1.26M | 276.00K |
|
|||||
Common Stock & APIC | 35.59M | 31.59M | 30.30M | 12.64M | 12.00M |
Retained Earnings | -20.81M | -17.99M | -15.99M | -13.60M | -11.23M |
Treasury Stock & Other | -835.60K | -217.40K | -486.70K | -100.00 | -- |
Total Common Equity | 13.95M | 13.39M | 13.83M | -958.40K | 774.80K |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 100.00 | 100.00 | 100.00 | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 100.00 | 100.00 | 100.00 | -- | -- |
|
|||||
Total Common Equity | 13.95M | 13.39M | 13.83M | -958.40K | 774.80K |
Total Preferred Equity | 100.00 | 100.00 | 100.00 | -- | -- |
Total Minority Interest | -1.10K | -800.00 | -400.00 | 0.00 | -- |
Total Equity | 13.95M | 13.39M | 13.83M | -958.50K | 774.80K |
|